» Articles » PMID: 39132394

Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Abstract

Background: Deferral of coronary revascularization is safe whether guided by instantaneous wave-free ratio (iFR) or by fractional flow reserve (FFR). We aimed to assess long-term outcomes in patients deferred from revascularization based on iFR or FFR in a large real-world population.

Methods: From 2013 through 2017, 201,933 coronary angiographies were registered in the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). We included all patients (n = 11,324) with at least 1 coronary lesion deferred from PCI during an index procedure using iFR (>0.89; n = 1998) or FFR (>0.80; n = 9326). The primary outcome was major adverse cardiac events (MACE) defined as the composite of all-cause death, nonfatal myocardial infarction, or unplanned revascularization. A multivariable-adjusted Cox proportional hazards model was used, with analysis for interaction of prespecified subgroups.

Results: Patients presented with stable angina pectoris (iFR 46.9% vs FFR 48.6%), unstable angina or non-ST-elevation myocardial infarction (iFR 37.7% vs FFR 33.1%), ST-elevation myocardial infarction (iFR 1.9% vs FFR 1.6%), and other indications (iFR 12.5% vs FFR 15.7%). The median follow-up was 2 years for both iFR and FFR groups. At the conclusion of the study, the cumulative MACE risks were 26.7 for the iFR group and 25.9% for FFR group. In the adjusted analysis, no difference was found between the 2 groups (adjusted hazard ratio: iFR vs FFR, 0.947; 95% CI, 0.84-1.08; = 39). Consistent with the overall findings, the prespecified subgroups showed no interaction with the FFR/iFR results.

Conclusions: Deferral of revascularization showed similar long-term safety whether based on iFR or on FFR.

Citing Articles

Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial.

Andersen B, Holm N, Mogensen L, Maillard L, Ramunddal T, Erriquez A EuroIntervention. 2025; 21(3):e161-e170.

PMID: 39750037 PMC: 11776405. DOI: 10.4244/EIJ-D-24-01001.

References
1.
Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019; 14(14):1435-1534. DOI: 10.4244/EIJY19M01_01. View

2.
Gotberg M, Berntorp K, Rylance R, Christiansen E, Yndigegn T, Gudmundsdottir I . 5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve. J Am Coll Cardiol. 2022; 79(10):965-974. DOI: 10.1016/j.jacc.2021.12.030. View

3.
Gotberg M, Cook C, Sen S, Nijjer S, Escaned J, Davies J . The Evolving Future of Instantaneous Wave-Free Ratio and Fractional Flow Reserve. J Am Coll Cardiol. 2017; 70(11):1379-1402. DOI: 10.1016/j.jacc.2017.07.770. View

4.
Zimmermann F, Ferrara A, Johnson N, van Nunen L, Escaned J, Albertsson P . Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015; 36(45):3182-8. DOI: 10.1093/eurheartj/ehv452. View

5.
Nascimento B, Belfort A, Macedo F, SantAnna F, Pereira G, Costa M . Meta-analysis of deferral versus performance of coronary intervention based on coronary pressure-derived fractional flow reserve. Am J Cardiol. 2014; 115(3):385-91. DOI: 10.1016/j.amjcard.2014.11.014. View